Companies Dominating the Dermal Filler Landscape
- Allergen
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merz Pharma
- Sinclair Pharma
- Galderma Laboratories
- BioPlus Co., Ltd.
- Candela Corporation
- BIOXIS pharmaceuticals
- Suneva Medical
- SCULPT Luxury Dermal Fillers Ltd
- Dr. Korman Laboratories Ltd.
- Evolus Inc.
Key players in the market are now focusing on bringing more sustainable and less-toxic solutions, such as hyaluronic acid-based products. They are also producing long-acting embellishments to support optimum performance from their offerings. This is helping them acquire consumer trust and solidify their leadership in this merchandise. For instance, in June 2023, Galderma attained FDA approval for its hyaluronic acid filler, Restylane Eyelight, to treat undereye hollows in adults over 21. The new dermal filler is formulated with NASHA Technology to deliver water-resistance and natural-looking results. Such innovations are inspiring other competitors to create more innovative solutions. This cohort of players includes:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Dermal Filler Market in 2025 is estimated at USD 6.83 billion.
The global market size was around USD 6.36 billion in 2024 and is likely to expand at a CAGR of more than 9.3%, surpassing USD 20.21 billion revenue by 2037.
North America retains the largest share, supported by economic stability and a rise in cosmetic procedures.
The major players in the market include Allergen, Merz Pharma, Sinclair Pharma, Galderma Laboratories, BioPlus Co., Ltd., Candela Corporation, BIOXIS pharmaceuticals, Suneva Medical, SCULPT Luxury Dermal Fillers Ltd, Dr. Korman Laboratories Ltd.
